Wood creosote

DB13271InvestigationalSmall molecule

Wood creosote: Overview.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 4 and 5-hydroxytryptamine receptor 3
Curator reviewed
Also known as: Creosote

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of September 14, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

19Marketed productsAcross 2 countries and 11 labellers

1ATC codeIncluding every combination product, plus 5 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Wood creosote, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.